TickerFactsScreenerDevelopers

Niagen Bioscience, Inc. (NAGE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$4.10M2012: -$10.12M2013: -$3.91M2015: -$2.58M2016: -$2.94M2017: -$9.80M2018: -$20.91M2019: -$20.44M2020: -$10.60M2021: -$24.16M2022: -$15.10M2023: $7.12M2024: $12.11M2025: $13.50M$13.50M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$13.50M+11.5%
2024$12.11M+70.1%
2023$7.12M+147.1%
2022-$15.10M+37.5%
2021-$24.16M-128.0%
2020-$10.60M+48.1%
2019-$20.44M+2.2%
2018-$20.91M-113.3%
2017-$9.80M-233.9%
2016-$2.94M-13.8%
2015-$2.58M—
2013-$3.91M+61.4%
2012-$10.12M-146.9%
2011-$4.10M—